Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope.
antiangiogenic drugs
antiresorptive drugs
bisphosphonates
medication-related osteonecrosis of the jaw
peri-implantitis
Journal
Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
revised:
11
03
2021
received:
22
12
2020
accepted:
05
04
2021
pubmed:
13
4
2021
medline:
12
8
2022
entrez:
12
4
2021
Statut:
ppublish
Résumé
In the recent years, an increasing number of peri-implant medication-related osteonecrosis of the jaw (PI-MRONJ) have been reported in literature, both in oncologic and osteoporotic patients. The aim of this study is to describe 19 cases of patients previously diagnosed as affected by peri-implantitis, who were treated for PI-MRONJ, with consideration on clinical and histopathological features. Patients included were affected by postmenopausal osteoporosis and were administered with different antiresorptive drugs. Due to the presence of clinical and radiological signs of peri-implantitis not healed after non-surgical periodontal treatment, they were referred to the Complex Operating Unit of Odontostomatology of the University of Bari. Then, after a drug holiday of at least 3 months and cycles of antibiotics, and after other cycles of periodontal treatment, patients underwent the surgical removal of implant fixtures and surrounding bone. Although the previous diagnosis of peri-implantitis, the histopathological analysis with both conventional and confocal laser scanner microscopy confirmed the diagnosis of peri-implantitis-like MRONJ. Peri-implantitis not healed after conventional treatment in patients at risk on MRONJ occurrence should be considered as peri-implantitis-like PI-MRONJ and treated as required in order to get complete healing of the pathological condition, thus avoiding delay in the diagnosis.
Identifiants
pubmed: 33844402
doi: 10.1111/odi.13873
pmc: PMC9541517
doi:
Substances chimiques
Bone Density Conservation Agents
0
Diphosphonates
0
Types de publication
Journal Article
Langues
eng
Pagination
1603-1609Informations de copyright
© 2021 The Authors. Oral Diseases published by Wiley Periodicals LLC.
Références
J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56
pubmed: 25234529
J Oral Maxillofac Surg. 2010 Jul;68(7):1662-6
pubmed: 20561470
J Clin Periodontol. 2018 Jun;45 Suppl 20:S286-S291
pubmed: 29926491
Int J Environ Res Public Health. 2020 Aug 18;17(16):
pubmed: 32824826
J Prosthodont Res. 2010 Jul;54(3):108-11
pubmed: 20434422
Int J Dent. 2014;2014:935657
pubmed: 24995017
J Craniomaxillofac Surg. 2016 Dec;44(12):1945-1951
pubmed: 27836551
J Can Dent Assoc. 2007 Jun;73(5):417-22
pubmed: 17555652
Am J Case Rep. 2017 Dec 19;18:1351-1356
pubmed: 29257800
J Oral Maxillofac Surg. 2008 Feb;66(2):223-30
pubmed: 18201600
J Dent Res. 2007 Nov;86(11):1013-21
pubmed: 17959890
Implant Dent. 2006 Sep;15(3):212-8
pubmed: 16966893
Curr Med Chem. 2017;24(28):3068-3076
pubmed: 28494743
J Oral Maxillofac Surg. 2010 Apr;68(4):790-6
pubmed: 20307764
Bone. 2009 Sep;45(3):406-13
pubmed: 19450715
Int J Oral Maxillofac Surg. 2019 Dec;48(12):1530-1532
pubmed: 31378564
J Oral Maxillofac Surg. 2003 Sep;61(9):1115-7
pubmed: 12966493
Clin Oral Investig. 2013 Jan;17(1):167-75
pubmed: 22415216
J Biol Regul Homeost Agents. 2014 Jul-Sep;28(3):523-9
pubmed: 25316140
Case Rep Dent. 2016;2016:2856926
pubmed: 27088019
J Oral Maxillofac Surg. 2010 Feb;68(2):337-43
pubmed: 20116705
Oral Dis. 2022 Sep;28(6):1603-1609
pubmed: 33844402
Clin Implant Dent Relat Res. 2011 Mar;13(1):58-63
pubmed: 19681933
Clin Oral Implants Res. 2014 May;25(5):632-40
pubmed: 23278625
J Oral Maxillofac Surg. 2008 May;66(5):1022-4
pubmed: 18423296
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):2-12
pubmed: 19371809
Int J Dent. 2016;2016:1801676
pubmed: 27843453